Atezolizumab for Idiopathic Pulmonary Fibrosis

NCT05515627 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Atezolizumab

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]